EcoDrugPlus

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSBGRG00000020676
Gene Symbol: CSF1R
1 Cross references
273 Possible Orthologues:

Complement C1s

Ensembl ID : ENSBGRG00000020327
Gene Symbol: C1S
1 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSBGRG00000011687
Gene Symbol: C5
1 Cross references
212 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSBGRG00000020822
Gene Symbol: CRHR1
1 Cross references
208 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSBGRG00000024441
Gene Symbol: CCND1
1 Cross references
274 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSBGRG00000025652
Gene Symbol: CDK1
1 Cross references
245 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSBGRG00000000696
Gene Symbol: CDK2
1 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSBGRG00000005577
Gene Symbol: CDK5
1 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSBGRG00000016959
Gene Symbol: CDK6
1 Cross references
201 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSBGRG00000006586
Gene Symbol: CDK9
1 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSBGRG00000014355
Gene Symbol: CYSLTR1
1 Cross references
181 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSBGRG00000021895
Gene Symbol: CYP26A1
1 Cross references
208 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).